Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
NCT05745285 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400
Last updated 2026-02-20
Summary
The purpose of this study is to learn about the impact that the services and programs provided by Blood Cancer United (formerly, The Leukemia and Lymphoma Society) have among patients with blood cancer, such as access to care, quality of life, and financial burden.
Conditions
- Leukemia
- Lymphoma
- Myeloma
- Myelodysplastic Syndromes
- Myeloproliferative Neoplasm
Interventions
- OTHER
-
LLS Program
The intervention will be conducted virtually. Participants will receive LLS's free patient and caregiver services including co-pay assistance, transportation and urgent need assistance, a scholarship program for young adult patients and survivors, one-on-one peer-to-peer support, online chats and support groups facilitated by clinical social workers, and nutrition counseling with a registered dietician for 6 months.
Sponsors & Collaborators
-
Blood Cancer United
collaborator OTHER -
University of Miami
lead OTHER
Principal Investigators
-
Frank Penedo, PhD · University of Miami
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-02-04
- Primary Completion
- 2026-10-31
- Completion
- 2026-11-01
Countries
- United States
Study Locations
More Related Trials
-
A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)
NCT06287528 ·Status: RECRUITING ·Phase: PHASE1
-
Dasatinib in Relapsed Chronic Lymphocytic Leukemia
NCT00438854 ·Status: COMPLETED ·Phase: PHASE2
-
Therapy of Chronic Lymphocytic Leukemia With Dasatinib (BMS-354825)
NCT00364286 ·Status: COMPLETED ·Phase: PHASE2
-
Predictors of Health-Related QOL in Adults With CLL or Small Lymphocytic Lymphoma
NCT07030400 ·Status: RECRUITING
-
Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia
NCT00588809 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
NCT05702645 ·Status: RECRUITING
-
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT01142427 ·Status: COMPLETED
-
Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT00482352 ·Status: COMPLETED
-
Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
NCT01253070 ·Status: COMPLETED ·Phase: PHASE2
-
Description and Prognostic Evaluation of Four Biological Parameters of Blast Cells in Adult Acute Lymphoblastic Leukemia
NCT00188084 ·Status: UNKNOWN
-
Resistance to Methotrexate in Patients With Acute Lymphoblastic Leukemia in Relapse or Remission
NCT00899899 ·Status: COMPLETED
-
Studying Biomarkers in Cell Samples From Patients With Acute Myeloid Leukemia
NCT01057199 ·Status: COMPLETED
-
Vaccine Immune Recovery After Leukemia
NCT05622682 ·Status: COMPLETED
-
A Study for Patients With Acute Leukemia
NCT01214655 ·Status: TERMINATED ·Phase: PHASE1
-
Dasatinib in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia
NCT00254423 ·Status: COMPLETED ·Phase: PHASE2
-
Studying Biomarkers in Cell Samples From Young Patients With Acute Myeloid Leukemia
NCT01057290 ·Status: COMPLETED
-
Study of Lenalidomide in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
NCT01433965 ·Status: COMPLETED ·Phase: PHASE1
-
Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)
NCT00759798 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Metabolic Syndrome in Young Patients Who Are Acute Lymphoblastic Leukemia Survivors and Their Healthy Siblings
NCT00897078 ·Status: COMPLETED
-
A Study Being Conducted at Multiple Locations to Compare Safety and Efficacy of Three Different Regimens; (1) High-Dose Lenalidomide; (2) Lenalidomide + Azacitidine; or (3) Azacitidine in Subjects ≥ 65 Years With Newly-Diagnosed Acute Myeloid Leukemia
NCT01358734 ·Status: COMPLETED ·Phase: PHASE2
-
Studying Biomarkers as a Diagnostic Tool in Samples From Younger Patients With B-Cell Acute Lymphoblastic Leukemia
NCT01540578 ·Status: COMPLETED
-
EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer
NCT00004258 ·Status: COMPLETED ·Phase: PHASE1
-
Sorafenib Plus 5-Azacitidine Initial Therapy of Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MS) With FLT3-ITD Mutation
NCT02196857 ·Status: COMPLETED ·Phase: PHASE2
-
Dasatinib in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia
NCT00345826 ·Status: COMPLETED ·Phase: PHASE1
-
Biomarkers in Bone Marrow Samples From Young Patients With Acute Myeloid Leukemia
NCT01298414 ·Status: COMPLETED